A multicenter, randomized, double-blind, placebo-controlled, intraindividual-comparison phase IIa trial to evaluate the efficacy and safety of 2% AVT-02 UE ointment in the treatment of mild to moderate psoriasis vulgaris

Registry ID

EUCTR2007-000462-21

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Avontec GmbH

Start date

2008-01-04

Completion date

2008-06-06

Last update

2026-08-16

Conditions

• psoriasis vulgaris

Summary

The primary objective is to evaluate the efficacy and safety of two different dosage regimens of 2% AVT-02 UE ointment in subjects with psoriasis vulgaris compared to placebo as assessed by SOS of marker plaques and safety data during a 4 weeks treatment. The primary objectives will be evaluated by an intra-individual comparison within each treatment arm. The treatment arms will be compared in a separate exploratory analysis

Locations

• , , Germany

View on source registry